Skip to main content
. 2017 Jun 8;12(6):e0179366. doi: 10.1371/journal.pone.0179366

Fig 1. Survival curves of GBM patients stratified by the results of HCMV UL73.

Fig 1

(A) The median progression-free survival of HCMV UL73 positive cases (5.6 months) was shorter than that of HCMV UL73 negative cases (7.5 months). However, their difference was not significant (p = 0.147). (B) The median overall survival of HCMV UL73 positive cases (14.6 months) was shorter than those of HCMV UL73 negative cases (19.2 months). However, their difference was not significant (p = 0.141).